Warning: This security is no longer trading.
defunct
Tocagen Inc. (TOCA): Price and Financial Metrics
TOCA Price/Volume Stats
| Current price | $1.26 | 52-week high | $6.77 |
| Prev. close | $1.31 | 52-week low | $0.42 |
| Day low | $1.22 | Volume | 761,400 |
| Day high | $1.50 | Avg. volume | 1,472,422 |
| 50-day MA | $1.24 | Dividend yield | N/A |
| 200-day MA | $1.04 | Market Cap | 30.14M |
TOCA Stock Price Chart Interactive Chart >
Tocagen Inc. (TOCA) Company Bio
Tocagen Inc., a clinical-stage company, focuses on developing gene therapy candidates to activate a patient’s immune system against their cancer in the United States. The company is developing Toca 511 & Toca FC that is in Phase II/III clinical trial for patients with recurrent high grade glioma (HGG); and Phase Ib clinical trial for the intravenous treatment of metastatic colorectal, pancreatic, breast, lung, melanoma, and renal cancers, as well as in preclinical stage for newly diagnosed HGG. The company was founded in 2007 and is based in San Diego, California.
TOCA Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | 68.22% |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | 0.00% |
| 2019 | -93.51% |
Continue Researching TOCA
Here are a few links from around the web to help you further your research on Tocagen Inc's stock as an investment opportunity:Tocagen Inc (TOCA) Stock Price | Nasdaq
Tocagen Inc (TOCA) Stock Quote, History and News - Yahoo Finance
Tocagen Inc (TOCA) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...